ResMed Inc (RMD)
245.66
+2.05
(+0.84%)
USD |
NYSE |
Nov 05, 16:00
244.58
-1.08
(-0.44%)
After-Hours: 18:24
ResMed Net Income (Annual): 1.021B for June 30, 2024
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.021B |
| June 30, 2023 | 897.56M |
| June 30, 2022 | 779.44M |
| June 30, 2021 | 474.50M |
| June 30, 2020 | 621.67M |
| June 30, 2019 | 404.59M |
| June 30, 2018 | 315.59M |
| June 30, 2017 | 342.28M |
| June 30, 2016 | 352.41M |
| June 30, 2015 | 352.89M |
| June 30, 2014 | 345.27M |
| June 30, 2013 | 307.13M |
| June 30, 2012 | 254.85M |
| June 30, 2011 | 226.99M |
| June 30, 2010 | 190.08M |
| June 30, 2009 | 146.45M |
| Date | Value |
|---|---|
| June 30, 2008 | 110.30M |
| June 30, 2007 | 66.30M |
| June 30, 2006 | 88.21M |
| June 30, 2005 | 64.78M |
| June 30, 2004 | 57.28M |
| June 30, 2003 | 45.73M |
| June 30, 2002 | 37.51M |
| June 30, 2001 | 11.63M |
| June 30, 2000 | 22.23M |
| June 30, 1999 | 16.10M |
| June 30, 1998 | 10.60M |
| June 30, 1997 | 7.50M |
| June 30, 1996 | 4.50M |
| June 30, 1995 | 2.80M |
| June 30, 1994 | 1.20M |
| June 30, 1993 | 0.80M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
474.50M
Minimum
2021
1.021B
Maximum
2024
758.82M
Average
779.44M
Median
2022
Net Income (Annual) Benchmarks
| Boston Scientific Corp | 1.593B |
| Abbott Laboratories | 5.723B |
| Becton Dickinson & Co | 1.484B |
| Insulet Corp | 206.30M |
| Twist Bioscience Corp | -204.62M |